(Q33208795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Justine Rudner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Verena Jendrossek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kirsten Lauber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Peter T Daniel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Claus Belka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

130-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

Safety and antitumor activity of recombinant soluble Apo2 ligand

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Apoptosis-modulating agents in combination with radiotherapy-current status and outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Potential and caveats of TRAIL in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Functional screening of genes suppressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-XL and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

An induced proximity model for caspase-8 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Pro-caspase-3 is a major physiologic target of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Influence of hypoxia on TRAIL-induced apoptosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

Inhibition of Bid-induced apoptosis by Bcl-2. tBid insertion, Bax translocation, and Bax/Bak oligomerization suppressed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

[Death inducing ligands in combination with ionizing radiation: objective and current knowledge].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Many cuts to ruin: a comprehensive update of caspase substrates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Bcl-2 does not inhibit cell death induced by the physiological Fas ligand: implications for the existence of type I and type II cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Celecoxib activates a novel mitochondrial apoptosis signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Intracellular mediators of erucylphosphocholine-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

New insights in the role of Bcl-2 Bcl-2 and the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Caspases: Intracellular Signaling by Proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Differences between CD95 type I and II cells detected with the CD95 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208191

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15531922%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 January 2020

1030634267

0 references

1 reference